FDA — authorised 4 December 2002
- Application: NDA050788
- Marketing authorisation holder: PADAGIS US
- Local brand name: CENTANY
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA authorised Mupirocin ointment on 4 December 2002
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 4 December 2002; FDA has authorised it.
PADAGIS US holds the US marketing authorisation.